Screener
Tenet Healthcare THC Impairment and restructuring charges, and acquisition-related costs
Impairment and restructuring charges, and acquisition-related costs at other companies
Other financials
Where this comes from
Reported directly by Tenet Healthcare in its filing.
Tagged under the XBRL concept thc:RestructuringSettlementImpairmentProvisionsAndAcquisitionCost.
The source filing: Tenet Healthcare’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:27 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0000070318-26-000037
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Supplies | 984 | 932 | 1,945 | 1,839 |
| Other operating expenses, net | 1,174 | 1,119 | 2,296 | 2,209 |
| Depreciation and amortization | 215 | 208 | 444 | 414 |
| Impairment and restructuring charges, and acquisition-related costs | 31 | 24 | 55 | 43 |
| Litigation and investigation costs | 3 | 28 | 30 | 45 |
| Net losses (gains) on sales, consolidation and deconsolidation of facilities | (33) | 38 | (34) | 16 |
| Operating income | 1,501 | 823 | 2,797 | 1,766 |
| Interest expense | (204) | (206) | (409) | (410) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Tenet Healthcare's impairment and restructuring charges, and acquisition-related costs?
- Tenet Healthcare (THC) reported impairment and restructuring charges, and acquisition-related costs of $31M in Q2 2026.
- How has Tenet Healthcare's impairment and restructuring charges, and acquisition-related costs changed year-over-year?
- Tenet Healthcare's impairment and restructuring charges, and acquisition-related costs increased by 29.2% year-over-year, from $24M to $31M.
- What is the long-term trend for Tenet Healthcare's impairment and restructuring charges, and acquisition-related costs?
- Over 4 years (2021 to 2025), Tenet Healthcare's impairment and restructuring charges, and acquisition-related costs has grown at a 11.2% compound annual growth rate (CAGR), from $85M to $130M.
- What does impairment and restructuring charges, and acquisition-related costs mean?
- This captures non-cash charges related to the impairment of assets, restructuring of business operations, or costs associated with significant legal settlements. These are excluded from operating cash flow to provide a clearer view of recurring operational performance.
Ask your AI about Tenet Healthcare's impairment and restructuring charges, and acquisition-related costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude